To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene RECQL5TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
223 supporting clones for gene RECQL5 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AB042824 testis .a 1 to 3703 1 to 3703 exact tiling clone,   3703/3703
(100 %)
2 diff
(100.0 %id)
DA064794 cerebellum .a 1 to 562 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA136305 alzheimer cortex .a 4 to 633 2 to 631   capped   630/630
(100 %)
3 diff
(99.6 %id)
DA784712 brain .a 4 to 584 2 to 582   capped   581/585
(99 %)
3 diff
(99.5 %id)
NM_004259.5   .a 5 to 3687 1 to 3683 exact RefSeq, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 3683/3683
(100 %)
0 diff
(100 %id)
DB091647 testis .a 6 to 551 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
BP225902   .a 7 to 588 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BP358418 mammary gland .a 7 to 587 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
DA589799 lung .a 8 to 566 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
CB155215 brain .a 9 to 507 1 to 499       499/499
(100 %)
2 diff
(99.6 %id)
DA413309 thalamus .a 10 to 563 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DB222883 trachea .a 10 to 585 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA014548 adrenal gland .a 11 to 586 2 to 578   capped   577/577
(100 %)
1 diff
(99.9 %id)
BP357881 mammary gland .a 11 to 592 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
DA543365   .a 12 to 572 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
BP360479 thalamus .a 12 to 593 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DA768272 brain .a 13 to 541 2 to 530   capped   529/530
(99 %)
1 diff
(99.9 %id)
DB167099 kidney, tumor tissue .a 13 to 567 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
DR002020 fetal brain .a 14 to 736 1 to 723       723/723
(100 %)
3 diff
(99.6 %id)
DA261194 caudate nucleus .a 16 to 576 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
BG762566 melanotic melanoma, high MDR (cell line), skin .a 27 to 887 1 to 859       859/859
(100 %)
16 diff
(98.2 %id)
BG763254 melanotic melanoma, high MDR (cell line), skin .a 27 to 811 1 to 807       807/810
(99 %)
50 diff
(93.9 %id)
BP237318 coronary artery .a 30 to 610 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
BQ932656 large cell carcinoma, lung .a 30 to 917 1 to 897       897/900
(99 %)
15 diff
(98.4 %id)
BQ924931 large cell carcinoma, lung .a 30 to 884 1 to 856       856/857
(99 %)
9 diff
(99.0 %id)
BQ954275 large cell carcinoma, lung .a 30 to 925 1 to 898       898/899
(99 %)
9 diff
(99.0 %id)
BG721800 testis .a 31 to 760 1 to 726       726/727
(99 %)
9 diff
(98.8 %id)
CD102768 Pooled-Skin .a 33 to 602 1 to 575       575/812
(70 %)
21 diff
(97.5 %id)
AL525351 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 34 to 931 1 to 897       897/897
(100 %)
21 diff
(97.7 %id)
BX426657 T cells (Jurkat cell line) .a 34 to 681 1 to 649       649/649
(100 %)
26 diff
(96.0 %id)
EF560729 salivary gland .a 36 to 3687 1 to 3652 Y927H tiling clone, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 3652/3652
(100 %)
4 diff
(99.9 %id)
DA584755 lung .a 37 to 624 2 to 589   capped   588/588
(100 %)
1 diff
(99.9 %id)
CN429146 embryonic stem cells, cell lines H1, H7, andH9 .a 43 to 725 1 to 683       683/683
(100 %)
2 diff
(99.8 %id)
DB284378 uterus .a 45 to 589 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
CF135552 lymph .a 46 to 545 1 to 500       500/500
(100 %)
20 diff
(96.0 %id)
TI_154163966   .a 52 to 702 62 to 712       651/907
(71 %)
30 diff
(96.7 %id)
BQ375153 testis_normal .a 72 to 547 1 to 476       476/476
(100 %)
8 diff
(98.4 %id)
BQ322863 colon_est .a 73 to 426 1 to 354       354/354
(100 %)
2 diff
(99.5 %id)
DB052765 testis .a 83 to 641 2 to 560   capped   559/559
(100 %)
2 diff
(99.7 %id)
AB006533 testis .a 161 to 1393 1 to 1233       1233/1233
(100 %)
0 diff
(100 %id)
CN429147 embryonic stem cells, cell lines H1, H7, andH9 .a 332 to 720 1 to 387       387/387
(100 %)
2 diff
(99.5 %id)
BU187406 eye, retinoblastoma .a 363 to 1201 1 to 845       845/845
(100 %)
7 diff
(99.2 %id)
BI916256 brain .a 402 to 1125 1 to 723       723/723
(100 %)
1 diff
(99.9 %id)
TI_57239782   .a 402 to 1125 28 to 750       723/750
(96 %)
1 diff
(99.9 %id)
BG424888 Kidney, renal cell adenocarcinoma .a 509 to 1097 1 to 589       589/589
(100 %)
0 diff
(100 %id)
BQ316263 colon .a 731 to 1348 1 to 619       619/619
(100 %)
1 diff
(99.9 %id)
AW368882 head_neck .a 738 to 1026 1 to 289       289/289
(100 %)
3 diff
(99.0 %id)
BQ049337 lymph, lymphoma, cell line .a 861 to 1709 1 to 853       853/870
(98 %)
31 diff
(96.5 %id)
BU431740 lymph .a 867 to 1288 8 to 429     Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 422/429
(98 %)
7 diff
(98.4 %id)
TI_154153697   .a 867 to 1366 79 to 578       500/500
(100 %)
1 diff
(99.8 %id)
BQ059196 lymph, lymphoma, cell line .a 875 to 1808 1 to 939       937/982
(95 %)
14 diff
(98.6 %id)
BQ061205 lymph, lymphoma, cell line .a 875 to 1672 1 to 806       806/975
(82 %)
16 diff
(98.4 %id)
BX099953 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 879 to 1320 20 to 462       443/462
(95 %)
12 diff
(97.5 %id)
AI567000 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 879 to 1252 19 to 395     Submitted on the opposite strand 377/395
(95 %)
9 diff
(97.8 %id)
BF182856 large cell carcinoma, lung .a 1144 to 1878 14 to 743       731/753
(97 %)
29 diff
(96.2 %id)
BP378835 uterus .a 1164 to 1736 1 to 572       572/573
(99 %)
14 diff
(97.6 %id)
BI200066 brain, neuroblastoma .a 1234 to 1789 1 to 560       560/560
(100 %)
13 diff
(97.7 %id)
BI198364 brain, neuroblastoma .a 1235 to 1533 1 to 301       301/1212
(24 %)
5 diff
(99.6 %id)
BC000570 Brain, neuroblastoma .a 1236 to 3686 1 to 2451   available from MGC, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 2451/2451
(100 %)
3 diff
(99.9 %id)
BE261456 brain, neuroblastoma .a 1255 to 1878 1 to 618       618/709
(87 %)
25 diff
(96.5 %id)
BE313572 brain, neuroblastoma .a 1255 to 1878 1 to 620   available from MGC,   620/713
(86 %)
7 diff
(99.1 %id)
BE314216 brain, neuroblastoma .a 1255 to 1892 1 to 634       634/634
(100 %)
8 diff
(98.8 %id)
BE263134 brain, neuroblastoma .a 1256 to 2100 1 to 845       845/914
(92 %)
27 diff
(97.1 %id)
BG325004 Kidney, renal cell adenocarcinoma .a 1398 to 2107 1 to 707       707/742
(95 %)
6 diff
(99.2 %id)
BY798643 eye .a 1427 to 2044 1 to 618       618/618
(100 %)
3 diff
(99.6 %id)
BQ370620 placenta_normal .a 1468 to 1651 1 to 184       184/184
(100 %)
3 diff
(98.4 %id)
BQ316256 colon .a 1575 to 2081 597 to 91       507/597
(84 %)
2 diff
(99.7 %id)
AI906586 breast .a 1628 to 1938 23 to 334       312/340
(91 %)
12 diff
(96.5 %id)
CF143912 lymph .a 1658 to 2058 1 to 401       401/401
(100 %)
2 diff
(99.6 %id)
CF144202 lymph .a 1658 to 1967 1 to 310       310/310
(100 %)
2 diff
(99.4 %id)
TI_154175623   .a 1665 to 2078 80 to 493       414/414
(100 %)
0 diff
(100 %id)
TI_154176182   .a 1665 to 2122 78 to 535       458/461
(99 %)
8 diff
(98.3 %id)
BI017099 lung_tumor .a 1740 to 1971 14 to 246       232/250
(92 %)
11 diff
(95.6 %id)
BG107326 lymph, lymphoma, cell line .a 1836 to 2336 1 to 500       500/500
(100 %)
2 diff
(99.6 %id)
BG326701 Kidney, renal cell adenocarcinoma .a 1838 to 2645 1 to 803       803/842
(95 %)
50 diff
(94.1 %id)
BX383323   .a 1878 to 2649 1 to 794       794/863
(92 %)
53 diff
(93.9 %id)
BU178842 eye, retinoblastoma .a 1903 to 2649 11 to 765       755/977
(77 %)
24 diff
(97.6 %id)
BG386599 adenocarcinoma cell line, colon .a 1917 to 2555 1 to 638       638/638
(100 %)
4 diff
(99.4 %id)
BG823856 adenocarcinoma cell line, colon .a 1917 to 2610 1 to 695       695/702
(99 %)
14 diff
(98.1 %id)
BU170416 epithelioid carcinoma, Pancreas .a 1969 to 2648 1 to 683       683/886
(77 %)
10 diff
(98.9 %id)
CF145949 CNCAP(3)T-225 cell line, Prostate .a 1997 to 2463 1 to 467       467/467
(100 %)
6 diff
(98.8 %id)
TI_154178247   .a 2003 to 2551 80 to 628       549/549
(100 %)
4 diff
(99.3 %id)
BM479653 eye, retinoblastoma .a 2026 to 2741 1 to 716       716/1033
(69 %)
29 diff
(97.2 %id)
BU955994 adenocarcinoma, cell line, breast .a 2028 to 2739 1 to 713       713/937
(76 %)
10 diff
(99.0 %id)
BQ878810 dorsal root ganglia .a 2109 to 2649 1 to 542       542/1034
(52 %)
12 diff
(98.9 %id)
BG770389 melanotic melanoma, high MDR (cell line), skin .a 2167 to 2559 27 to 417       391/417
(93 %)
6 diff
(98.6 %id)
BI257568 cervical carcinoma cell line, cervix .a 2185 to 2966 1 to 773       773/827
(93 %)
15 diff
(98.2 %id)
BE409899 choriocarcinoma, placenta .a 2269 to 2966 1 to 697   available from MGC,   697/801
(87 %)
16 diff
(98.1 %id)
BG335140 choriocarcinoma, placenta .a 2276 to 3100 1 to 823       823/920
(89 %)
17 diff
(98.2 %id)
BG336687 choriocarcinoma, placenta .a 2276 to 3043 1 to 771       771/862
(89 %)
37 diff
(95.8 %id)
BG773941 choriocarcinoma, placenta .a 2276 to 2866 1 to 590       590/590
(100 %)
3 diff
(99.5 %id)
BC005103 Placenta, choriocarcinoma .a 2277 to 3703 1 to 1427   available from MGC, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 1427/1427
(100 %)
1 diff
(100.0 %id)
CR602281 Neuroblastoma Cot 50-normalized .a 2363 to 3667 1 to 1305       1305/1305
(100 %)
0 diff
(100 %id)
AL530834 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .a 2363 to 3035 1 to 673       673/1080
(62 %)
4 diff
(99.7 %id)
BE798468 lung, small cell carcinoma .a 2375 to 3242 19 to 877       859/919
(93 %)
29 diff
(96.9 %id)
BE541900 cervix .a 2443 to 3082 1 to 635       635/635
(100 %)
15 diff
(97.7 %id)
AA156212 Pancreas .a 2458 to 2778 1 to 327       325/340
(95 %)
17 diff
(95.0 %id)
AA325147 brain, cerebellum .a 2481 to 2680 1 to 200       200/200
(100 %)
3 diff
(98.5 %id)
AW964872   .a 2482 to 2969 1 to 489       489/497
(98 %)
11 diff
(97.8 %id)
BG821355 adenocarcinoma cell line, colon .a 2561 to 3350 1 to 789       789/789
(100 %)
3 diff
(99.7 %id)
CK826135 insulinoma, Pancreas .a 2695 to 3159 1 to 465   fully sequenced, Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 465/465
(100 %)
6 diff
(98.8 %id)
AW351959 head_neck .a 2729 to 3347 1 to 618       618/618
(100 %)
4 diff
(99.4 %id)
AW365200 head_neck .a 2735 to 3289 1 to 556       557/556
(100 %)
21 diff
(96.3 %id)
C19080 placenta .a 2742 to 3135 1 to 387       390/393
(99 %)
14 diff
(96.5 %id)
AL525305 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 2744 to 3628 902 to 19       884/909
(97 %)
7 diff
(99.3 %id)
BG754457 B-cells, primary B-cells from tonsils (cell line) .a 2758 to 3509 1 to 816       611/816
(74 %)
52 diff
(93.7 %id)
R31058 placenta .a 2866 to 3286 1 to 429       429/431
(99 %)
23 diff
(94.7 %id)
TI_159681487   .a 2952 to 3687 846 to 117   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 730/948
(77 %)
21 diff
(97.8 %id)
AW366079 head_neck .a 2994 to 3385 397 to 1       397/397
(100 %)
12 diff
(97.0 %id)
BU956240 adenocarcinoma, cell line, breast .a 3007 to 3703 1 to 700   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 700/700
(100 %)
4 diff
(99.5 %id)
BF035697 adenocarcinoma, ovary .a 3016 to 3679 1 to 655       655/875
(74 %)
16 diff
(98.2 %id)
CB528675 Aveolar Macrophage, lung .a 3022 to 3703 698 to 17   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 682/682
(100 %)
0 diff
(100 %id)
AL530833 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .a 3067 to 3666 600 to 1       600/1131
(53 %)
20 diff
(98.3 %id)
BQ478242 insulinoma, Pancreas .a 3129 to 3687 575 to 17   fully sequenced, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 559/559
(100 %)
1 diff
(99.9 %id)
BX426656 T cells (Jurkat cell line) .a 3173 to 3688 513 to 1       513/896
(57 %)
15 diff
(98.4 %id)
AA156333 Pancreas .a 3274 to 3702 437 to 1       437/437
(100 %)
15 diff
(96.6 %id)
AW574991 lymph .a 3382 to 3712 348 to 18   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 331/331
(100 %)
3 diff
(99.1 %id)
BC063440 Uterus, leiomyosarcoma .b 1 to 3575 1 to 3575 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 3575/3575
(100 %)
3 diff
(100.0 %id)
BM449612 leiomyosarcoma, uterus .b 1 to 804 1 to 812       812/1011
(80 %)
19 diff
(98.2 %id)
BX335086 Placenta Cot 25-normalized .c 1 to 1062 1 to 1050   tiling clone, fully sequenced,   1050/1050
(100 %)
37 diff
(96.5 %id)
BX335085 Placenta Cot 25-normalized .c 1054 to 1970 922 to 21   tiling clone, fully sequenced,   902/922
(97 %)
24 diff
(97.4 %id)
CV575026 cornea, eye .d 1 to 634 1 to 634   tiling clone,   634/634
(100 %)
0 diff
(100 %id)
AF193041   .d 7 to 3095 1 to 3089 exact tiling clone, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 3089/3089
(100 %)
4 diff
(99.9 %id)
BM458349 lymph, lymphoma, cell line .d 2216 to 3069 1 to 856       856/856
(100 %)
2 diff
(99.8 %id)
TI_149285082   .d 2265 to 3093 911 to 89   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 823/1071
(76 %)
26 diff
(97.6 %id)
CT003967 T-Lymphocytes .d 2267 to 2846 1 to 580       580/582
(99 %)
1 diff
(99.9 %id)
BF529616 anaplastic oligodendroglioma with 1p/19qloss, brain .d 2419 to 3023 1 to 621       621/1026
(60 %)
11 diff
(99.0 %id)
CR615823 B cells (Ramos cell line) Cot 25-normalized .d 2426 to 3095 1 to 670       670/670
(100 %)
0 diff
(100 %id)
BX342566   .d 2429 to 3040 613 to 1       613/616
(99 %)
2 diff
(99.7 %id)
BQ016513 lung, Metastatic Chondrosarcoma .d 2430 to 3085 672 to 17   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 656/663
(98 %)
1 diff
(99.9 %id)
BX342567   .d 2431 to 3095 1 to 665       665/665
(100 %)
2 diff
(99.7 %id)
BU615967 Bone, Subchondral Bone .d 2439 to 3085 664 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 646/646
(100 %)
2 diff
(99.7 %id)
AA424423.
matches multiple genes
  .d 2452 to 2977 1 to 527     also hits gene PCMTD2 527/527
(100 %)
9 diff
(98.3 %id)
CB529933 Aveolar Macrophage, lung .d 2454 to 3069 637 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 619/619
(100 %)
2 diff
(99.7 %id)
AL040751 testis .d 2457 to 3053 596 to 1       596/601
(99 %)
1 diff
(99.9 %id)
CA424228 cell lines, Chondrosarcoma .d 2457 to 3095 657 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 639/639
(100 %)
0 diff
(100 %id)
BI003682 head_normal .d 2480 to 2888 408 to 1       408/418
(97 %)
34 diff
(91.9 %id)
BU680726 lung .d 2534 to 3093 579 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 561/561
(100 %)
1 diff
(99.9 %id)
BM931339 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 2569 to 3069 1 to 501       501/501
(100 %)
1 diff
(99.9 %id)
H41073 eye, retina .d 2595 to 3069 474 to 1       474/475
(99 %)
21 diff
(95.6 %id)
AA682447 liver and spleen .d 2595 to 3085 498 to 13   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 486/486
(100 %)
5 diff
(99.0 %id)
CD107955 brain, Pituitary .d 2595 to 3068 1 to 473   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 473/473
(100 %)
1 diff
(99.8 %id)
AW297405   .d 2621 to 3045 8 to 432     Submitted on the opposite strand 425/432
(98 %)
6 diff
(98.7 %id)
AI885851 anaplastic oligodendroglioma, brain .d 2635 to 3086 452 to 1       452/452
(100 %)
4 diff
(99.2 %id)
AI085666 anaplastic oligodendroglioma, brain .d 2654 to 3086 436 to 4       433/436
(99 %)
0 diff
(100 %id)
BM703334 eye, human retina .d 2658 to 3074 1 to 417       417/417
(100 %)
3 diff
(99.3 %id)
AW167138 serous papillary carcinoma, high grade, 2pooled tumors, uterus .d 2670 to 3086 422 to 6       417/432
(96 %)
0 diff
(100 %id)
AI123482 parathyroid gland, parathyroid tumor .d 2673 to 3095 430 to 8       423/430
(98 %)
0 diff
(100 %id)
AI660179 thymus, pooled .d 2683 to 3096 415 to 4       412/415
(99 %)
0 diff
(100 %id)
AI127287 heart .d 2689 to 3086 405 to 8       398/405
(98 %)
0 diff
(100 %id)
AI500263 anaplastic oligodendroglioma, brain .d 2695 to 3083 422 to 33   AAA   390/401
(97 %)
0 diff
(100 %id)
AI915815 Kidney .d 2697 to 3086 391 to 2       390/391
(99 %)
0 diff
(100 %id)
AA580761 bulk germ cell seminoma .d 2712 to 3069 374 to 17   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 358/358
(100 %)
9 diff
(97.5 %id)
M79162   .d 2721 to 3078 360 to 1       360/360
(100 %)
2 diff
(99.5 %id)
AI208664   .d 2732 to 3095 367 to 4       364/367
(99 %)
0 diff
(100 %id)
AI569551 serous papillary carcinoma, high grade, 2pooled tumors, uterus .d 2736 to 3096 379 to 20   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 360/360
(100 %)
6 diff
(98.4 %id)
AW167346 serous papillary carcinoma, high grade, 2pooled tumors, uterus .d 2736 to 3075 340 to 1       340/340
(100 %)
10 diff
(97.1 %id)
TI_154132436   .d 2736 to 3094 424 to 65   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 360/1227
(29 %)
8 diff
(99.4 %id)
AI282276 Kidney, renal cell tumor .d 2737 to 3086 357 to 9       349/357
(97 %)
0 diff
(100 %id)
BU856811 adenocarcinoma, cell line, breast .d 2783 to 3085 1 to 303   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 303/303
(100 %)
0 diff
(100 %id)
AW445145   .d 2787 to 3086 316 to 17       300/326
(92 %)
0 diff
(100 %id)
AW451279   .d 2787 to 3085 314 to 16   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 299/309
(96 %)
1 diff
(99.7 %id)
AI473731 Kidney .d 2811 to 3086 299 to 25       275/299
(91 %)
0 diff
(100 %id)
AI537901 serous papillary carcinoma, high grade, 2pooled tumors, uterus .d 2811 to 3069 290 to 31   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 260/266
(97 %)
12 diff
(95.5 %id)
AW132126 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .d 2819 to 3075 257 to 1       257/257
(100 %)
2 diff
(99.3 %id)
AW242764 Kidney .d 2847 to 3086 251 to 12       240/251
(95 %)
0 diff
(100 %id)
AW243851 serous papillary carcinoma, high grade, 2pooled tumors, uterus .d 2898 to 3086 189 to 1       189/189
(100 %)
2 diff
(99.0 %id)
BF940035 brain, glioblastoma (pooled) .d 2900 to 3085 186 to 1       186/190
(97 %)
0 diff
(100 %id)
AI564910 anaplastic oligodendroglioma, brain .d 2918 to 3085 168 to 1       168/170
(98 %)
0 diff
(100 %id)
BX390887   .d 2963 to 3095 1 to 133       133/141
(94 %)
5 diff
(96.5 %id)
AA047018 eye, retina .e 1 to 519 1 to 515   tiling clone, Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 515/515
(100 %)
4 diff
(99.3 %id)
AA047034 eye, retina .e 1655 to 2182 545 to 13   tiling clone, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 533/533
(100 %)
9 diff
(98.4 %id)
BC016911 Duodenum, adenocarcinoma .f 1 to 1919 1 to 1919 exact tiling clone, available from MGC, AAA   1919/1919
(100 %)
0 diff
(100 %id)
BF982170 duodenal adenocarcinoma, cell line, small intestine .f 1 to 783 1 to 780   available from MGC,   780/909
(85 %)
19 diff
(98.0 %id)
AB042825 testis .g 1 to 1749 1 to 1749 exact tiling clone,   1749/1749
(100 %)
1 diff
(100.0 %id)
NM_001003715.2   .g 1 to 1743 1 to 1743 exact RefSeq, AAA   1743/1743
(100 %)
0 diff
(100 %id)
AK075084 placenta .g 10 to 1749 1 to 1740 I72N tiling clone, available from FLJ,   1740/1740
(100 %)
1 diff
(100.0 %id)
DA828654 placenta .g 11 to 727 2 to 725   capped   724/767
(94 %)
18 diff
(97.7 %id)
AA155882   .g 1018 to 1320 1 to 303       303/627
(48 %)
8 diff
(98.8 %id)
DB373232 placenta .g 1287 to 1749 463 to 1       463/463
(100 %)
0 diff
(100 %id)
AA155835   .g 1310 to 1744 436 to 1       436/629
(69 %)
1 diff
(99.9 %id)
AB042823 testis .h 1 to 3710 1 to 3715 exact tiling clone,   3715/3715
(100 %)
12 diff
(99.7 %id)
NM_001003716.2   .h 1 to 3710 1 to 3710 exact RefSeq,   3710/3710
(100 %)
0 diff
(100 %id)
CD300014 testis .h 674 to 1459 1 to 804       804/894
(89 %)
8 diff
(99.2 %id)
BI116483 lung, small cell carcinoma .h 1320 to 2034 1 to 708   tiling clone,   708/719
(98 %)
9 diff
(98.8 %id)
AW379653 head_neck .h 1526 to 2138 628 to 14   tiling clone,   615/628
(97 %)
0 diff
(100 %id)
AW380705 head_neck .h 1550 to 2116 1 to 565       565/565
(100 %)
16 diff
(97.2 %id)
AW379646 head_neck .h 1559 to 2138 24 to 608       585/659
(88 %)
28 diff
(95.8 %id)
AW380706 head_neck .h 1563 to 2138 1 to 573       573/613
(93 %)
24 diff
(96.1 %id)
AW379647 head_neck .h 1570 to 2136 1 to 564       564/564
(100 %)
16 diff
(97.2 %id)
BQ014395 Chondrosarcoma, Left Pubic Bone .h 1576 to 2206 648 to 19   AAA   630/630
(100 %)
2 diff
(99.7 %id)
AW380712 head_neck .h 1884 to 2142 267 to 3       265/270
(98 %)
0 diff
(100 %id)
AI686448 serous papillary carcinoma, high grade, 2pooled tumors, uterus .h 1962 to 2208 257 to 11   AAA   247/247
(100 %)
0 diff
(100 %id)
AI684041 serous papillary carcinoma, high grade, 2pooled tumors, uterus .h 1994 to 2431 450 to 13       438/450
(97 %)
0 diff
(100 %id)
BP272369   .h 2258 to 2819 1 to 562       562/562
(100 %)
3 diff
(99.5 %id)
N53539 multiple sclerosis lesions .h 2441 to 2862 423 to 1       423/432
(97 %)
5 diff
(98.9 %id)
AI537883 serous papillary carcinoma, high grade, 2pooled tumors, uterus .h 2517 to 2861 395 to 51   AAA   345/345
(100 %)
20 diff
(94.3 %id)
BU899225 Spleen .i 1 to 542 1 to 548   tiling clone,   548/904
(60 %)
16 diff
(98.3 %id)
BG768957 melanotic melanoma, high MDR (cell line), skin .i 339 to 1015 1 to 679   tiling clone,   679/712
(95 %)
19 diff
(97.4 %id)
CA391600 eye, RPE/choroid .i 837 to 1452 1 to 616   tiling clone,   616/616
(100 %)
1 diff
(99.9 %id)
BM469366 lymph, lymphoma, cell line .j 1 to 726 1 to 739 E197X tiling clone,   735/974
(75 %)
12 diff
(98.8 %id)
CB270726 adipose .j 51 to 530 1 to 480       480/480
(100 %)
1 diff
(99.8 %id)
BF896709 marrow .j 330 to 816 14 to 499   tiling clone,   486/499
(97 %)
7 diff
(98.6 %id)
BF896710 marrow .j 334 to 808 16 to 489   tiling clone,   474/489
(96 %)
7 diff
(98.6 %id)
AL136869 testis .k 1 to 1176 1 to 1176 exact tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 1176/1176
(100 %)
0 diff
(100 %id)
CR533497   .k 36 to 755 1 to 720 exact     720/720
(100 %)
1 diff
(99.9 %id)
BF822744 kidney_tumor .l 1 to 233 102 to 334   tiling clone,   233/334
(69 %)
7 diff
(98.0 %id)
BF823675 kidney_tumor .l 88 to 441 403 to 50   tiling clone, Submitted on the opposite strand 354/403
(87 %)
1 diff
(99.8 %id)
BF823674 kidney_tumor .l 103 to 416 320 to 7     Submitted on the opposite strand 314/320
(98 %)
2 diff
(99.4 %id)
BG010148 placenta_normal .l 319 to 651 334 to 2   tiling clone,   333/344
(96 %)
3 diff
(99.2 %id)
TI_159701423   .m 1 to 707 838 to 123 G5X I6M V7C Y8T C9A ... tiling clone,   710/1091
(65 %)
20 diff
(98.2 %id)
CN429148 embryonic stem cells, cell lines H1, H7, andH9 .n 1 to 656 1 to 656 N9M V10S R11G F12L V13S ... tiling clone,   656/656
(100 %)
3 diff
(99.6 %id)
CF994380 Human Placenta, placenta .o 1 to 712 18 to 743 exact tiling clone,   726/834
(87 %)
30 diff
(96.5 %id)
BE646407 B-cell, chronic lymphotic leukemia .p-u 1 to 702 703 to 1 exact tiling clone,   703/711
(98 %)
5 diff
(99.3 %id)
BF512418   .p-u 227 to 701 471 to 1 exact     471/474
(99 %)
7 diff
(98.6 %id)
AI660301 thymus, pooled .p-u 322 to 702 381 to 1 exact     381/381
(100 %)
0 diff
(100 %id)
DA948742 Spleen .q-u 1 to 556 2 to 557 exact tiling clone, capped   556/556
(100 %)
0 diff
(100 %id)
DA413094 thalamus .q-u 17 to 573 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
DB215784 trachea .q-u 17 to 378 2 to 364   capped   363/363
(100 %)
1 diff
(99.8 %id)
DA910109   .q-u 44 to 601 2 to 560   tiling clone, capped   559/559
(100 %)
1 diff
(99.9 %id)
DA350569 substantia nigra .r-u 1 to 575 2 to 576 exact tiling clone, capped   575/575
(100 %)
0 diff
(100 %id)
AW605932 head_neck .r-u 262 to 512 277 to 28       250/292
(85 %)
0 diff
(100 %id)
DA621660 Kidney .s 1 to 546 2 to 548 exact tiling clone, capped   547/547
(100 %)
2 diff
(99.7 %id)
DA857004 placenta .t 1 to 542 2 to 543 exact tiling clone, capped   542/542
(100 %)
0 diff
(100 %id)
AI218469 pooled .u 1 to 452 456 to 5 exact     452/456
(99 %)
0 diff
(100 %id)
AI363275 brain, glioblastoma (pooled) .u 1 to 518 521 to 4 exact tiling clone,   518/521
(99 %)
0 diff
(100 %id)
CV362477 ovary .va-u 1 to 295 1 to 294 P8L V9C G11A W13G W14G ... tiling clone,   294/294
(100 %)
3 diff
(99.0 %id)
EF491799   .vb 1 to 182 1 to 182 exact tiling clone,   182/182
(100 %)
0 diff
(100 %id)
AK304168 trachea Gene RECQL5, variant not shown         Suspected internal deletion, suspected internal deletion, this clone was ignored    
BF743980 breast Gene RECQL5, variant not shown              
AL600850   Gene RECQL5, variant not shown         Suspected internal deletion, this clone was ignored    
AI310229 2 pooled tumors (clear cell type), Kidney Gene RECQL5, variant not shown       AAA Suspected internal deletion, internal priming: the 3' end of the oligo dt primed clone lies in the CDS, this clone was ignored    
AI671940 Kidney Gene RECQL5, variant not shown       AAA Suspected internal deletion, internal priming: the 3' end of the oligo dt primed clone lies in the CDS, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p-u, .q-u, .r-u, .s, .t, .u, .va-u, .vb Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI